New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?

TH Chen - International journal of molecular sciences, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …

Astrocytes influence the severity of spinal muscular atrophy

H Rindt, Z Feng, C Mazzasette… - Human molecular …, 2015 - academic.oup.com
Systemically low levels of survival motor neuron-1 (SMN1) protein cause spinal muscular
atrophy (SMA). α-Motor neurons of the spinal cord are considered particularly vulnerable in …

Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA)

S Lefebvre, C Sarret - Archives de Pédiatrie, 2020 - Elsevier
Autosomal-recessive spinal muscular atrophy (SMA) is characterized by the loss of specific
motor neurons of the spinal cord and skeletal muscle atrophy. SMA is caused by mutations …

Spinal muscular atrophy: diagnosis and management in a new therapeutic era

WD Arnold, D Kassar, JT Kissel - Muscle & nerve, 2015 - Wiley Online Library
Spinal muscular atrophy (SMA) describes a group of disorders associated with spinal motor
neuron loss. In this review we provide an update regarding the most common form of SMA …

Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology

M Bowerman, JP Michalski, A Beauvais… - Human molecular …, 2014 - academic.oup.com
Spinal muscular atrophy (SMA) is characterized by motor neuron loss, caused by mutations
or deletions in the ubiquitously expressed survival motor neuron 1 (SMN1) gene. We …

Neurodegeneration in spinal muscular atrophy: from disease phenotype and animal models to therapeutic strategies and beyond

UR Monani, DC De Vivo - Future neurology, 2014 - Taylor & Francis
Of the numerous inherited diseases known to afflict the pediatric population, spinal muscular
atrophy (SMA) is among the most common. It has an incidence of approximately one in …

Spinal muscular atrophies: recent insights and impact on molecular diagnosis

C Brahe, E Bertini - Journal of molecular medicine, 1996 - Springer
Spinal muscular atrophies (SMA) are a group of motor neuron diseases characterized by
degeneration of anterior horn cells of the spinal cord and by muscular atrophy. Childhood …

Advances in spinal muscular atrophy therapeutics

V Parente, S Corti - Therapeutic advances in neurological …, 2018 - journals.sagepub.com
Spinal muscular atrophy (SMA) is a progressive, recessively inherited neuromuscular
disease, characterized by the degeneration of lower motor neurons in the spinal cord and …

Spinal muscular atrophy

JR Nance - CONTINUUM: Lifelong Learning in Neurology, 2020 - journals.lww.com
PURPOSE OF REVIEW This article provides an overview of the pathophysiology and clinical
presentations of spinal muscular atrophy (SMA) and reviews therapeutic developments …

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy

DMK Leow, YK Ng, LC Wang, HWL Koh, T Zhao… - The Journal of Clinical …, 2024 - jci.org
Spinal muscular atrophy (SMA) is typically characterized as a motor neuron disease, but
extraneuronal phenotypes are present in almost every organ in severely affected patients …